1. Composition for injection containing activated by peroxisome proliferators gamma receptor for subcutaneous administration. The composition according to claim 1, containing at least one peroxisome proliferator-activated gamma receptor selected from the group consisting of eicosanoids, in particular prostaglandins, such as Δ12-prostaglandin J2 and 15-deoxy-Δ12-prostaglandin J2, thiazolidine derivatives, such as rosiglitazone, siglitazone, troglitazone, englitazone and pioglitazone, non-steroidal anti-inflammatory drugs, unsaturated fatty acids, alpha-linoleic acid, arachidonic acid, docosahexaenoic acid, eicosapentaenoic acid, biphenyl derivatives roizvodnye amide N- (phenyl-oxazol-4-yl-methoxymethyl) -cyclohexyl-succinic acid and their smesi.3. The composition according to claim 1, containing retinoic acid, retinol, retinal and / or retinoid receptor X.4. The composition according to claim 1, wherein the content of the gamma receptor-activated peroxisome proliferators is from about 0.00001% by weight to about 5% by weight, based on the total weight of the composition. The composition according to claim 2, wherein the content of the agonist activated by peroxisome gamma receptor proliferators is from about 0.00001% by weight to about 5% by weight, based on the total weight of the composition. The composition according to claim 3, wherein the content of retinoic acid, retinol, retinal or retinoid X receptor is from about 0.00001% by weight to about 5% by weight, based on the total weight of the composition. The composition according to claim 1, additionally containing a skin-filling substance selected from the group consisting of collagen, cross-linked collagen, hyaluronic acid, cross-linked hyaluronic acid, polylactic acid1. Композиция для инъекций, содержащая активируемый пролифераторами пероксисом гамма-рецептор для подкожного введения.2. Композиция по п.1, содержащая, по меньшей мере, один активируемый пролифераторами пероксисом гамма-рецептор, выбранный из груп
